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Abstract
The amine-carboxyboranes anti-inflammatory agents were shown to block
TNF release at 90 min. and IL-I release at 5 hr. from macrophages.
The agenst competed with L929 fibroblasts high affinity receptors for
endogenous cytokines which regulate the inflammation process. Blocking
the TNF receptor at 90 min. by the agents from i0 to 50 M, resulted in
lysosomal hydrolytic enzyme inhibition and lowering of prostaglandin
synthesis as well as reductions in calcitonin high affinity receptor
binding and calcium influx into the cells. ILol receptors when blocked
by the agents at 5 hr. resulted in a reduction of NAG activity and
leukotriene synthesis. An elevation of proline incorporation into
collagen occurred at 90 min. and 24 hr. in the presence of the agents.
Introduction
Amine-carboxyboranes and related derivatives have been shown to be
potent anti-inflammatory and antioosteoporosis agents in rodentsI’4.
These agents were shown to block septic shock, pleurisy, arthritis and
induced edema in mice at doses from 2 to 8 mg/kgI. Previous studies
have demonstrated that these agents reduced hydrolytic enzyme
activities, in addition to prostaglandin and leukotriene synthesis in
macrophages, leukocytes and Be Sal osteoporotic cells3. Other studies
have indicated in vivo and in vitro that the amine-carboxyboranes
reduced TNF and IL-I levels after challenge with LPS1,2 Cytokine
release from inflammatory cells is related to the induction of fever,
acute phase response and release of secondary chemical mediators, e.g.
prostalandins and leukotrienes5. IL-I is a pyrogenic and chemotaxic
factoru. Studies have demonstrated that TNF is maximally released
from IC-21 mouse macrophages from 60 to 90 min whereas ILol is maximally
released from P388D macrophages at 5 to 8 hrI.
Methods
The amine carboxyborane derivatives were previously snthesized and the
chemical and physical characteristics reported I]: Compound
(C6H5)3PBH2COOH Compound # CI6H33N(CH3)2BH2COOH and Compound
(CH3)3NBH2COOCH3. The standards, Tumor necrosis factor alpha, TNF and
interleukineol, IL-I, were obtained from Sigma Chemical Co. (St. Louis,
MO).
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Cell MaintenanceI 7
IC-21 mouse macrophages (RPMI 1640 + i0 FCS + P/S) and L929 mouse
fibroblasts (EMEM + I0 FCS + P/S) were grown to confluency in 6 well
plates for the following assays. IC-21 macrophages were selected
because they release cytokine as well as hydrolytic enzymes and
secondary chemical mediators of inflammation. L929 fibroblasts were
selected because they are inflammatory target tissue cells which contain
high affinity receptors for cytokines and are responsible for wound
repair after injury has occurred. TNF= release from ICo21 macrophages
peaks at 90 min. and the effects of the agents from 12.5 to 50 M were
determined at 90 min and 5 hr. IL-I release from P388D macrophages was
determined at 90 min. and 5 hr. The cytotoxic L929 bioassay was used to
quantitate the cytokine levelsl, 7.
High Affinit Binding to Receptors on L929 or IC-21 Cells8
Two Ci of I51-TNF. (human recombinant 30 mCi/ug New England Nuclear)
or 1251-IL-I (70-120Ci/g, New England Nuclear) was added to confluent
L929 or ICo21 mouse fibroblasts or macrophages for 30 to 120 rain with
the amine-carboxyboranes from I0 to 50 p. These cells were chosen
because they have plama membrane high affinity receptors for these
specific cytokines. After the allotted time period, the medium was
gently decanted and the cells were washed 6 X in cold isotonic PBS, pH
7.2. The cells were taken up in 0.1N NaOH and aliquots were counted.
1251 Calcitonin (human, 2000 Ci/nmole, Amersham) or 3H- i, 25-
dihyroxyvitamin D3 (155-175 Ci/mmole, New England Nuclear) [I0 Ci] was
added to confluent L929 cells with drugs from i0 to I00 M and incubated
90 rain or 5 hr. Cells were washed repeatedly in PBS and taken up in 0.I
N NaOH. In the case of 1,25-dihydro-vitamin D3, the nuclei preparation
was obtained. The aliquots were counted in a Pachard beta counter
corrected for quenching, and non-specific binding of isotopes.
45Ca Uptake by Ceils and 3H Proline Incorporation into Collagen of L929
Cells9, I0
45CACI2 (0.2 mCi, New England Nuclear) was added to confluent L929
cells. The medium was decanted and the cells were washed 4 times with
PBS, pH 7.2. The cells were taken up in 0.1N NaOH and counted. L929
cells (70 confluent) were incubated with i Ci of 2,3,4,5-3H-proline
(102 Ci/mmol, New England Nuclear) and drugs. After 24 hr, the medium
was discarded and the cells were washed repeatedly with PBS. The cells
were harvested in 0.1N NaOH. After treatment with 20 TCA, cells were
centrifuged at 3500 g X 5 rain. The supernatant was discarded and the
pellet was suspended in I ml of 50 mM Tris + 5 mM CaCI2 + 20 i of
collagenase (i0 mg/ml buffer, [Sigma Chemical Co. St. Louis, MO]) and
incubated for 2 hr at 37C. Tannic acid:TCA [i:I] (5) solution was
added and incubated for 15 min at room temperature followed by
centrifugation to separate the collagen from non-collagen proteinII.
Lysosomal Enzymes
IC-21 macrophages [108 were grown to confluency and incubated for 90
rain or 5 hr. with drugs at 12.5, 50 and i00 p2 Acid phosphatase
activities were determined using 0.i M -glycerolphosphate in 0.i M
acetate buffer, pH 5.0 1-3. Total enzyme was released with Triton X-100.
The reaction was terminated with I0 TCA and then the solution was
centrifuged at 3500 g for i0 min. The inorganic phosphate in the
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supernatant was determined spectrophotometrically at 800 nm by the
method of Chen et al. 12. N-Acetylglucosaminidase [NAG] activity was
determined by the method Tulberg-Reinert and Hetti13. ICo21 macrophages
were incubated with drugs at 12.5, 50 and i00 M for 90 rain, and 5 hr in
the presence of i0 ug/ml LPS (Salmonella abortus equi). The medium [50
I] was incubated with 7.5 mM p-nitrophenyl-N-acetyl--D-glucosaminide
in glycine buffer, pH 5.0 in 96-well microplates. The reaction was
stopped by the addition of glycine/EDTA buffer [50mM: 5mM] The
concentration of p-nitrophenol released was measured at 405 nm using a
microplate reader [Thermomax, Molecular Devices Corp. ].
Prostaglandin Synthetase Activity
The incubation procedures of Tomlinson et al. 14 and Glatt et al. 15 were
used to determine prostaglandin formation from 3H(N)oarachidonic acid
(I00 Ci/mmole) and IC-21 cells (106). After I hr, the reaction was
terminated with 2N HCI and the mixture was extracted with ether and
evaporated. The residue was dissolved in ethyl acetate and applied to
silica gel TLC plates which were eluted with chloroform, methanol, water
and acetic acid (90:8:1:0.8). The plates were developed with iodine
vapor and the area appropriate to the prostaglandin standards was
scraped and counted 14,15. The dpm in each area was calculated as
percent of the total dpm applied to the plate.
5’ -Lipoxygenase Assay
IC-21 cells were incubated for 30 min with phosphate buffer (pH 7.2)
containing 0.6 mM CaCI2, and 1.0 mM MgCI2 I0 mg Calcium lonophore
A23187 and I mCi iAC-arachidonic acid (I00 i/mmol). The reaction was
terminated with 2 volumes of EtOAc:CH2CI2 containing 12 mg cold
arachidonic acid. The organic phase was evaporated to a residue which
was applied to silica gel plates. The plates were eluted with
chloroform:methanol:water:acetic acid (90:8:1:0.8). The 5-HETE area
corresponding to the standard was scraped and counted 16,17.
Results
The LPS induced TNF release from IC-21 cells and IL-I release from
P388DI cells was maximum at 90 min. and 5 hr., respectively. LPS
concentration of 5, I0 and 20 g/ml of growth medium were examined in
both assays and i0 g/ml afforded the best release of TNF at 90 rain and
ILol at 5 hr. Thus, this concentration of LPS was selected for the
following studies. The reduction of TNF release caused by amine-
carboxyboranes from 12.5 to 50 M followed a concentration-response
curve over at 90 mi.n. and 5 hr [Table I]. It was interesting to note
that the agents still suppressed TNF= release from ICo21 macrophages at
5 hr. long after the peak release of the cytokine induced by LPS.
The effect of amine-carboxyboranes on the release of IL-I from P388DI
cells using I0 g/mi LPS at 90 minutes and 5 hours was reduced at all
concentrations of agents, but most significantly at 25 and 50 M (43-
100%) [Table 2]. FTrthermore, after 90 minutes in the presence of 50
M of Compounds #i and #3, and after 5 hours with 50 M of Compound #3,
IL-I release was inhibited 100%. The agents were able to suppress IL-I
release from P388DI cells at an early time i.e 90 min., when IL-I levels
were normally substantially lower after LPS induction [Table 3].
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Table I. The Effect of Amlne-Carboxyboranes on TNF Release from IC-2I
Cells in the Presence of 10 g/ml LPS
% of Control [.Nffi8]
Conc. COMPOUN #i COMPOUND 2 COMPOUND 3
M 90 min 5 hrs 90 min 5 hrs 90 min 5 hrs
0 ""II 1005a’ lO0+/-4b i’o0+/-ba 100b 100+/-’a’ 100+/-4b
12.5 II 81+/-4 95+/-4 90+/-6 86+/-5 50+/-5* 97+/-6
25 II 60+/-4* 66+/-5* 55+/-4* 524" 54+/-4* 57+/-5*
50 II 41+/-5" 29+/-3* 31+/-5" 31+/-3" 33+/-4* 29+/-3*
acontrol=171 ng TNF released’bControl=154, .2 ng TNF released’*p<, 0. 001
Table 2. The Effect of Amlne-Carboxyboranes on IL-I Release from P388DI
Cells in the Presence of 10 pg/ml LPS
% of Control IN 8]
Conc. M COMPOUND #I COMPOUND #2 COMPOUND #3
..0 rain hrs -m-ln?5-.rs 90 sin 5 hrs
0 100+/-6 a 100+/-6 b 100+/-6 a 100+/-6 b 100+/-6 a 100+/-6
12.5 98+/-7 96+/-6 93+/-5 57+/-4* 96+/-6 91+/-5
25 32+/-3* 51+/-4, 31+/-3, 52+/-6* 31+/-2- 32+/-3*
50 0 52+/-6W 57+/-5* 52+/-4* 0 0
acontrol=91.2 ng IL-I released;DControl=166.8 ng IL-I released;*p <0.001
TNF high affinity receptor binding on L929 cells was reduced with
amine-carboxyboranes at i0 BM from 30 to 120 rain. This is the same
period of time when the maximum release of TNF occurs from IC-21
macrophages. Higher concentration of the agents after 90 min incubation
did not improve the inhibition of TNF= high affinity binding to L929
fibroblast high affinity receptors [Table 4].
Table 3 The Effect of Amine-Carboxyboranes at i0 pM on TNF= High
Affinity Receptor Binding on L929 Cells
% of Control [N --6]
Control COMPOUND #i COMPOUND #2 COMPOUND #3 Time
(min.
30
60
90
120
I00+/-16a 75+/-9 74+/-7* 66+/-14"
i00+/-13b 84+/-6 78+/-12"* 827
I00+/-12c 89+/-8 62+/-8* 44+/-5*
i00+/-9d 12+/-5" 63+/-7* 17+/-5"
’a b Control Values 3656 CPM/mg protein; 6208 CPM/mg protein;
c 12819
CPM/mg protein; 11276 CPM/mg protein;*p<0.0001;**p<0.005.
ILol high affinity binding to L929 receptors was determined after 1.5,
5, 8, 24, 30 and 48 hours in the presence of amine-carboxyboranes at i0
M [Table 5]. IL-I high affinity receptor binding to L929 cells
significantly decreased over time by 53-68% after 5 hours for Compounds
# 2 and #3; however Compound #I caused only a 13% decrease in binding
at 90 minutes. IL-I high affinity receptor binding then increased again
in the presence of derivatives from 8 hours to 48 hours, At this latter
time, i.e. 48 hr., IL-I binding reached levels statistically above
control values.
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Table 4. The Effect of Amlne-Carboxyboranes on TNF High Affinity
Receptor Binding on L929 Cells After 90 Minutes
% of Control IN -6]
12.5 83_+5 76+_4*
25 78+_4* 94+_5
50 95+_7 II0_+I0
Control 100_+14% (1435 CPM/mg protein)* p<0.05
100+_9
109+_6
121_+14
Table 5. The Effect of Amlne-Carboxyboranes at i0 M on IL-I High
Affinity Receptor Binding on L929 Cells
% of Control [Nffi6]
Time Control Compound Compound Comp
(Hours) ,ll #z #2 ,ound,
1.5 I00+/-2a 87+/-4 53+/-2* 125+/-10
5 i00+/-8b 101+/-14 47+/-9* 32+/-13"
8 I00+/-6c 96+/-5 98+/-2 82+/-4
24 I00+/-7d 101+/-5 92+/-11 83+/-5
30 i00+/-5e 92+/-3 86+/-5 78+/-5*
48 I00+/-9f 130+/-4
b 163+/-7c 161+/-6"
a Control Vlues" 468 CPM/mg protein; 2108 CPM/mgprotein;
c 676 CPM/mg
protein; 439 CPM/mg protein; 397 CPM/mg protein;--ll5 CPM/mg protein;
* p 0.05.
IL- i high affinity binding L929 receptors after 5 hours was
significantly decreased from 41 to 55% of the control value [Table 6] at
all higher concentrations employed. Amine-carboxyboranes suppress IL-I
high affinity binding to fibroblast receptors at a time where maximum
IL-I binding has been demonstrated in this cell line, i.e. 5 hr.
The amine-carboxyboranes at 12.5, 25 and 50 pM significantly decreased
IL-I high affinity binding of IC-21 receptors at 90 rain. at a time when
time when maximum binding occurs in these fibroblasts [Table 7]. At 12.5
BM the maximum reduction of IL-I high affinity binding was
Table 6. The Effect of Amine-Carboxyboranes on IL-I High Affinity
Receptor Binding on L929 Cells After 5 Hours
% of Contro! [N =6]
Concentration,, COMPOUND #I COMPOUND #2 COMPOUND #3
25 45+_7* 50_+7* 41_+6,
50 49_+8* 43_+6* 50_+6*
Control 100_+9%(597 CPM/mg protein) ;* p<0. 0001
afforded; Compound #I reduced binding of ILol by 27%, Compound #2 by
58% and Compound #3 by 53%. Increased concentrations of the derivatives
did not improve the: reduction of IL-I binding to its high affinity
receptor in macrophages.
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Table 7. The Effect of Amine-Carboxyboranes on IL-1 High Affinity
Receptor Binding on IC-21 Cells After 90 Minutes
% of Control [N=6]
CncentratinllCOMPOUND#1(M)
COMPOUND#2 COMPOUND#3
25 69+/-4* 49+/-6* 48+/-4*
50 67+/-5* 46+/-2* 55+/-2*
Control=100+/-6% (820 CPM/mg protein.); *p < 0.001.
There was essentially no effect of amine-carboxyboranes at 12.5, 25 and
50 BM on NAG activity in IC-21 macrophages at 90 minutes or 5 hours
[Tables 8 and 9].
Table 8. The Effect of Amine-Carboxyboranes on NAG Activity of IC-21
Cells After 90 Minutes
% of Control[N--8]
Concentration COMPOUND #I COMPOUND #2
’12.5 9_+g 97+5" ’94+5
25 99+1 92+5 92+11
50 96+5 92+4 92+8
Control 100+4% (69 nmoles p-nitrophenol released/ml medium)
COMPOUND #3
Table 9. The Effect of Amine-Carboxyboranes on NAG Activity in IC-
21 Cells After 5 Hours
% of Control IN=8]
Concentration COMPOUND #I COMPOUND #2 COMPOUND #3
12.5505 iii
101+/-6
86+/-7
97+/-5
88+/-6
91+/-9
9i+/-6’
Control 100+/-7% (80.4 nmoles p-nitrophenol released/ml medium)
ICo21 cells when incubated for 24, 48 and 72 hours in the presence of
amine-carboxyboranes at i or I0 M and NAG activity showed moderate
reductions in NAG activity (Table i0). Compounds #I and #3 demonstrated
similar reductions in activity at 24 hours. Maximum reduction of NAG
activity occurred at 48 hours at i0 BM for all compounds.
In ICo21 cells after incubation with amine-carboxyboranes for 90
minutes, acid phosphatase activity was reduced by Compound #2 at 12.5 M
and Compound #3 at 25 M. Compound #I caused a 74-78% reduction of acid
phosphatase activity at 25 and 50 M (Table Ii). No concentration
dependent pattern was evident for the three compounds at 90 min.
At 5 and 18 hours the effects of the amine-carboxyboranes on ICo21
macrophage acid phosphatase activity were generally less; nevertheless,
the values were significantly reduced from the control value (Table 12-
13).
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Table i0. The Effect of Amlne-Carboxyboranes at i or i0 M on NAG
Activity in IC-21 Cells
% of Contro![N=8]
Time Control C,ompound #I Compound #2 ...Co,mpound #3
(,hu....rs), II, t a-
24 I00+2 74+/-4* 71+/-1" 99+/-16 104+/-3 79+/-8* 74+/-2*
48 I0054D 82+/-4* 63+/-5* 89+/-4 48+/-2* 83+/-4 66+1-
72 i0055 c 122+4 88+2 97+3 86+3 99+3 9+3- Control Values" 84 nmoles p-nitrophenol released/ml medium; 150
nmoles p-nitrophenol released/ml medium;
c 174 nmoles p-nitrophenol
released/ml medium;* p<0.0001;
Table ii. The Effect of Amine-Carboxyboranes on Acid Phosphatase
Activity in iC-21 Cells After 90 Minutes
% of Control [N--10]
Concentration
12.5
25
50
COMPOUND #i COMPOUND #2 COMPOUND #3
ND 11+2. 66+7*
22+4* 32+7* 11+3-
26+4* 24_+7* 35+5*
Control 100+6% (260 mg Pi/mg protein/90 minutes);* p<0.0001; ND not
determined.
Table 12. The Effect of Amine-Carboxyboranes on Acid Phosphatase
Activity in IC-21 Cells After 5 Hours
%, of, Con,,trol [N=I0]
COMPOUND #i COMPOUND #2 COMPOUND #3 Concentration
12.5
25
50
8+8 80+7* 93+6
78+4* 55+2* 58+7*
25+_6* 55+8* 51+7-
Control 100+7% (380 mg Pi/mg protein/5 hours) ;*p<0.0001.
Prostaglandin cycloo-oxygenase activity in IC-21 cells was measured in
the presence of amine-carboxyboranes at 12.5, 25 and 50 M after 90
minutes and 5 hours. Prostaglandin cyclo-oxygenase activity was reduced
at all times in IC-21 macrophages. In IC-21 cells, prostaglandin cyclo-
oxygenase activity was maximally reduced by Compound #I at 90 minutes (
Table 14) and 5 hours at 50 M (Table 15). Compounds #2 and #3 at 50 M
demonstrated better reduction of activity at 90 minutes.
Concentration
12.5
25
50
Table 13. The Effect of Amine-Carboxyboranes on Acid Phosphatase
Activity in IG-21 Cells After 18 Hours
% of Control ([N--10]
COMPOUND #i COMPOUND #2 COMPOUND #3
55+5* 63+6* 99+_7
58_+6* 55+7* 28+3*
58+5* 62+5* 35+6*
Control 100+6% (500 mg Pi/mg protein/18 hours) ;* p<0.0001
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Table 14. The Effect of Amlne-Carboxyboranes on Prostaglandin Cyclo-
oxygenase Activity in IC-21 Cells After 90 Minutes
% of Control
Concentration COMPOUND #i COMPOUND #2 COMPOUND #3
12’5 53+4* 95+6 99+8
25 386" 787" 83i7
50 42i3" 66i5" 53++6*
Control 100+/-7% (16,020 DPM/mg protein);* p<O. 0001
Table 15. The Effect of Amlne-Carboxyboranes on Prostaglandln Cyclo-
oxygenase Activity in IC-21 Cells After 5 Hours
% of Control [N=6]
Concentration COMPOUND #I COMPOUND #2 COMPOUND #3
25 46+4* 109+7 68+4*
50 42+3* 94+4 68+4*
Control 100+6% (14,656 DPM/mg protein) ;*p<0.0001.
5’-Lipoxygenase activity in ICo21 cells was measured in the presence of
amine-carboxyboranes at 12.5, 25 and 50 M hours after 90 minutes or 5
hours. At 90 minutes incubation the magnitude of reduction of 5’
lipoxygenase activity in IC-21 cells was less with Compounds #2 and #3
which achieved a 33-39% reduction at 50 M (Table 16) than at 5 hours
incubation, when the 5’-lipoxygenase activity was reduced 46-52% by all
three of the amineocarboxyboarnes [Table 17].
Table 16. The Effect of Amlne-Carboxyboranes on 5’-Lipoxygenase Activity
in IC-21 Cells After 90 Minutes
% of Control [N--6]
COMPOUND #I COMPOUND #2 COMPOUND #3 Concentration
12.5
25
50
94+9 70+7*
89+5 69+9*
88+7 67+6*
Control 100+13 % (2902 DPM/mg protein) ;*p<0.0001
74+8*
65+6*
61+7"
The effect of amineocarboxyborane at I0 M on calcium uptake into L929
cells was measured at 1.5, 5, 8, 24 and 48 hours (Table 18). At all
times, the calcium uptake was decreased significantly and at 5 hours the
uptake of calcium by L929 cells to reach its lowest level for each
compound.
Table 17. The Effects of Amlne-carboxyboranes on 5’-Lipoxygenase
Activity of IC-21 Cells After 5 Hours
% of Control [N-6]
Concentration I[COMPOUND #i COMPOUND #2
I!
12.5 86+/-8** 69+/-6* 60+/-7*
25 52+/-8* 58+/-7* 56+/-5*
50 43+/-6* 54+/-5* 48+/-8*
Control 100+/-13 % (2902 DPM/mg protein);*p<0.0001;**p<0.025
COMPOUND #3
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Table 18. The Effect of Amlne-Carboxyboranes at 10 M on CalclumUptake
into L929 Cells
% of Control IN=8]
Time llControl COMPOUND #I COMPOUND #2 COMPOUND #3
,<hours) II.._
1.5 11’i00+23 35+/-22* 41+/-25" 46+/-10"
5 "DIII00I3 18+/-14" 44+/-14" 53+/-36*
8 ._IIi0017
c 39+/-31" 52+/-11" 53+/-36*
24 III00+ii
d 26+/-12" 42+/-15" 51+/-24"
48 III00717
e 47+13" 465" 35+12"
a c Control Values 2837 CPM/mg protein" 5457 CPM/mg protein" 3352 e CPM/mg protein; 3103 CPM/mg protein; 2434 CPM/mg protein;* p<0.0001
The effects of pure recombinant human TNF on calcium uptake in L929
cells can be compared to the effects of amine-carboxyboranes at I0 M
after 90 minutes. TNF= at i0 ng/ml and I00 ng/ml reduced calcium uptake
into L929 cells by 33% and 40%, respectively as 90 min.[data not shown].
Pure recombinant human TNF or amine-carboxyboranes were added to L929
cells and the effects on proline incorporation into collagen and non-
collagen were compared for 48 hr. Proline incorporation into collagen
was enhanced by the amine-carboxyboranes at 90 min. and at 24 hr. above
control values.
At 8 hours, Compounds #I and #3 caused a 32-34% reduction in proline
incorporation into non-collagen of L929 cells. A moderate increase was
observed at 90 min. Compound #2 was not effective in reducing proline
incorporation into non-collagen of L929 cells at any time [Table 20].
TNF at I0 or I00 ng/ml of medium did not affect the incorporation of
proline into collagen of L929 cells; however, proline incorporation into
non-collagen was reduced 24% at i0 ng but not at I00 ng/ml at 90 min.
incubation.
Table 19. The Effect of Amine-Carboxyboranes at i0 M on Incorporation
of Prollne into Collagen in L929 Cells
% of Control[N=6]
Control COMPOUND #i COMPOUND #2 COMPOUND #3 Time
(hours)
1.5
5
8
24
i00+/-15a 169+/-14" 114+/-15 127+/-8"
I00+/-13b 115+/-6 103+/-3 98+/-6
i00+/-8c 87+/-5 104+/-5 87+/-11
10010d 186+/-12" 142+/-11" 190+/-16"
48 I00+--5
e i1844
86+_15
ontrol Values "a 3061 DPM/ml 4738 DPM/ml *p<0.0001
2937 DPM/ml
e 7084 DPM/ml
c 2719 DPM/ml
82_+23
Proline incorporation into collagen in L929 cells after 5 hours in the
presence of amine-carboxyboarnes at 12.5, 25 and 50 M was generally
decreased (Table 21). Compound #I caused a 31- 33% reduction of
incorporation of proline at all concentrations of drug and was the most
effective agent. Compound #3 caused a 22-28% reduction at all
concentrations and Compound #2 was not as effective producing a 14%
reduction at 50 M.
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Table 20. The Effect of Amlne-Carboxyboranes at 10 M on Prollne
Incorporation into Non-Collagen in L929 Cells
% of Control IN=6]
(hrs)
I00_+8a 83_+5 88+5 92+_3
I00_+5b 102+_5 83_+7 107_+12
100+_8c 68_+3* 91+_4 66_+4*
d 100+_7 78_+7, 108_+15 174_+19*
1.5
5
8
24
48 100_+la7e 106_+% 89+_6c i125
Control Values" 285 DPM/ml; 209 DPM/ml; 310 DPM/ml; 1519 DPM/ml;
1266 DPM/ml; *p<0.00Ol.
Proline incorporation into non-collagen in L929 cells after 5 hours in
the presence of amlne-carboxyboranes at 12.5, 25 and 50 M was not
significantly changed at any concentration, but did decline 18% with
Compound #3 at 50 M. [Table 22].
Table 21. The Effect of Amlne-Carboxyboranes on Prollne Incorporation
Concentration
12.5 95+/-3
25 87+/-4
50 67+/-2* 86+/-3
Control=100+/-5% (8780 DPM/ml);*p<0.0001.
into Collagen in L929 Cells After 5 Hours
% of Control(N=6)
COMPOUND #I COMPOUND #2 COMPOUND #3
69_+2*
69___6*
78_+5*
72+_5*
76_+7*
Table 22. The Effect of Amlne-Carboxyboranes on Prollne Incorporation
into Non-Collagen in L929 Cells After 5 Hours
% of Control(N-6)
Concentration
12.5
25
5O
COMPOUND #1 COMPOUND #2 COMPOUND #3
111.+__3 95__+11 100__+5
87.+__10 92+__11 100__+5
103.’+/-10 111__+15 82__+13
Control=100_+5% (800 DPM/ml).
In L929 cells, calcitonin high affinity binding to receptors was
measured at 1.5, 5, 24, and 48 hours [Table 23]. High affinity
calcitonin binding was decreased 22% by Compound #2 and 31% by Compound
#3 at 5 hours. Compound #I afforded the best reduction of calcitonin
high affinity receptor binding at 48 hours (i.e. 30%) and the binding
was actually elevated significantly above the control at 5 hours (i.e.
48%). High affinity binding of DHD in L929 cells at 90 minutes in the
presence of amine-carboxyboranes at I0 M demonstrated significant
elevation, i.e. Compound #I caused a 21% increase, Compound #2 a 54%
increase and Compound #3 a 69% increase. Pure recombinant human TNFa
added to L929 cells caused an increased DHD high affinity binding by 42%
at i0 ng/ml and by 14% at i00 ng/ml.
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The amine-carboxyboranes appear to reduce TNF binding in L929
fibroblasts from 30 to 120 rain. The I0 BM concentration of the agents
appeared to afford the best response in displacing the radioactive TNF
which suggest at this concentration the agents were competitive with the
cytokine’s binding to this L929 protein receptor. This receptor is
important in the release of hydrolytic enzymes and proteolytic enzymes
which initiate and cause tissue damage to tissue. The amine-
Table 23. The Effect of Amlne-Carboxyboranes at i0 M on High Affinity
Binding of Calcltonln to Receptors on L929 Cells
% of Control (N=8)
CMPD #I CMPD #2 CMPD #3 Time Control
<hours)
i. 5 i00_+15a
5 i00_+13b
24 i00_+8c
48 i00_+i0d
104+/-12 82+/-6 77+/-8*
148+/-15" 78+/-14" 69+/-8*
117+/-11 66+/-13" 78+/-8*
70+/-13" 151+/-20" 143+/-13"
a b Control Vlues" 1526 CPM/mg protein; 1207 CPM/mg protein;C1353CPM/mg
protein; 907CPM/mg protein;* p<0.0001
carboxyboranes have previously been shown to significantly reduce the
release of these enzymes as well reduce their catalytic activities1,3.
The present study demonstrated that the time frame for the reduction of
acid phosphatase activity in the presence’s of the agents is consistent
with the time of maximum inhibition of TNF high affinity receptor
binding. The inhibition of TNF= receptor binding also correlated with
the agents’ ability to suppress the activity of the regulatory enzyme
for prostaglandin synthesis at 90 min. Both the inhibition of hydrolytic
enzyme activity and prostaglandin cyclo-oxygenase activity continued
through 5 to 18 hours. Similar observation have been made when amine
carboxyboranes were incubated with bone UMR-106 cells in that these same
biochemical parameters were first suppressed at 90 min. consistent with
suppression of the TNF receptor but continued for a much longer period
of time than when peaked binding occurred with this cytokine receptor7.
TNF release was 120 ng/ml at 90 min the eak but was still at 80 ng/ml
after 50 hr. well above background levels!. NAG hydrolytic activity was
not inhibited until 48 hr. 5’-Lipoxygenase activity was suppressed
after 5 hr rather than 90 min. The inhibition of this enzyme activity
by the agents correlated more with the observed suppression ILol high
affinity receptor binding than with suppression of TNF= high affinity
binding. Similar pa.rallels were observed when UMR-106 bone cells were
examined for effects of amineocarboxyboranes on cytokine high affinity
receptors7. Cytokines which are known to play a role in inflammation
are TNF, ILol, 11-6 and IL-8. Apparently TNF effects are early, e.g.
30 rain to 6 hr., this is followed by II-i effects which begin around 2
hr and continue for 12 hr. ILo8 is released late and has its high
affinity binding to its receptors from 24 to 48 hr.
Differences in response to the agents as well as the high affinity
receptors for cytokines involved calcium uptake in L929 cells and bone
UMR-106 cells Calcium uptake in bone cells peaked at 90 min and was
apparently suppressed by TNF or the agents binding to TNF high
267Vol. 2. No. 5. 199 The Relationship Between Cytokine Regulation and
Anti-InflammatoryAction of Amine-Carboxyborane
affinity receptor at 90 min. but at 5 hr. this process was reversed and
calcium uptake into bone cells was increased two fold at 5 to 8 hr7. In
L929 cells calcium uptake peaked at 5 hr. but was suppressed by the
agents from 90 min to 8 hr. The agents suppressed dihydrovitamin D3
binding to its nuclear receptor early but in bone cells increased the
binding at 8 to 24 hr. which correlates with the increased uptake
calcium into bone cells. Calcitonin high affinity binding was not
affected by the agents in a manner which would indicated it affects
calcium uptake. In vivo the amineocarboxyboranes cause an elevation of
PTH and 1,25-dihydrovitamin D3 after 14 days administration which
correlated directly with an increase in serum calcium levels2. Proline
incorporation into collagen on the other hand. peaked in bone cells at 5
to 8 hr. while in L929 cells it peaked at 24 hr. in the presence of the
agents. This process is required by both types of cells to increase
bone tensile strength and to repair wounds. Thus, there does appear to
be some tissue difference in response to the agents and the time of
their maximum effects in a given type of cell.
Since the amine-carboxyboranes are very potent anti- inflammatory
agentsI4, the fact that they are able to block TNF, ILol and IL-8
receptor binding acting as antagonists would certainly explain the
ability of the agents to reduce the inflammation process. The early
events of the inflammation process are probably mediated by invading
macrophages and PMNs. These cells possess high affinity cytokine
receptors which regulate the release and synthesis of hydrolytic and
proteolytic enzymes which cause local tissue damage, vaodilation,
generation of free radicals, infiltration of white blood cells, local
heat, septic skock and anorexic wasting. The latter stage involves
tissue repair conducted by fibroblasts which also possess high affinity
receptors for cytokines. Both types of cells, macrophages and
fibroblasts, contain high affinity receptors which regulate cellular
events, their own release and the release of other cytokines5,6. This
is a chain reaction over time; thus, it is important that an effective
anti-inflammatory drug block sequel events in the reaction as well as
stimulate the repair process. The amine-carboxyboranes appear to
achieve these goals and further investigation as potential therapeutic
agents is warranted.
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